These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15490419)

  • 21. [Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome].
    Hong LR; Chen YJ; Jiang QL; Jia RL; Li C; Feng LH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1033-1038. PubMed ID: 38101785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access.
    LeSar CJ; Merrick HW; Smith MR
    J Am Coll Surg; 1999 Jul; 189(1):73-9; discussion 79-81. PubMed ID: 10401743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.
    Galli M; Luciani D; Bertolini G; Barbui T
    Blood; 2003 Mar; 101(5):1827-32. PubMed ID: 12393574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.
    Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Iwatani Y; Kanakura Y
    Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays.
    Tsutsumi A; Hayashi T; Chino Y; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
    Mod Rheumatol; 2006; 16(3):158-64. PubMed ID: 16767554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients.
    Manns BJ; Burgess ED; Parsons HG; Schaefer JP; Hyndman ME; Scott-Douglas NW
    Kidney Int; 1999 Jan; 55(1):315-20. PubMed ID: 9893142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis.
    O'shea SI; Lawson JH; Reddan D; Murphy M; Ortel TL
    J Vasc Surg; 2003 Sep; 38(3):541-8. PubMed ID: 12947274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis.
    Violi F; Ferro D; Valesini G; Quintarelli C; Saliola M; Grandilli MA; Balsano F
    BMJ; 1990 Apr; 300(6732):1099-102. PubMed ID: 2111722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of thrombophilic risk factors on vascular access survival in chronic dialysis patients in a retrospective evaluation.
    Klamroth R; Orlovic M; Fritsche I; Seibt S; Seibt F; Wegscheider K; Landgraf H
    Vasa; 2013 Jan; 42(1):32-9. PubMed ID: 23385224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic thrombotic risk of antibodies against phosphatidylserine and prothrombin and β-2-glycoprotein I.
    Kim H; Kim JE; Hwang SM; Lee HR; Han KS; Kim HK
    Clin Appl Thromb Hemost; 2014 May; 20(4):442-7. PubMed ID: 23892687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
    Afeltra A; Vadacca M; Conti L; Galluzzo S; Mitterhofer AP; Ferri GM; Del Porto F; Caccavo D; Gandolfo GM; Amoroso A
    Arthritis Rheum; 2005 Jun; 53(3):452-9. PubMed ID: 15934123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heritable thrombophilia and hypofibrinolysis. Possible causes of retinal vein occlusion.
    Glueck CJ; Bell H; Vadlamani L; Gupta A; Fontaine RN; Wang P; Stroop D; Gruppo R
    Arch Ophthalmol; 1999 Jan; 117(1):43-9. PubMed ID: 9930159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placental histomorphology in unexplained foetal loss with thrombophilia.
    Vora S; Shetty S; Khare M; Ghosh K
    Indian J Med Res; 2009 Feb; 129(2):144-9. PubMed ID: 19293440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
    Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
    Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T; Ieko M; Bertolaccini ML; Ichikawa K; Tsutsumi A; Matsuura E; Koike T
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter.
    Yu A; Egberg N; Jacobson SH
    Scand J Clin Lab Invest; 2003; 63(2):127-33. PubMed ID: 12751694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between lupus anticoagulants and anticardiolipin antibodies in patients with prolonged activated partial thromboplastin times.
    Alving BM; Barr CF; Tang DB
    Am J Med; 1990 Feb; 88(2):112-6. PubMed ID: 2105643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.